Shimada Hideaki

52PUBLICATIONS

64CO-AUTHORS

Social epidemiologyPredictive and prognostic markersChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (52)

Sort by Publication Date:

|Jun 05, 2026

Outcomes of Gastric Cancer Surgery in Nonagenarians Compared With Patients Aged 85-89 Years: a Multi-Institutional Study.

|Apr 13, 2026

Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma.

Yosui Nojima, Fumiaki Shiratori, Takashi Suzuki

|Jan 05, 2026

Significance of Serum Tumor Markers in Esophageal and Gastric Cancers: A Systematic Literature Review.

Yasunori Matsumoto, Takeshi Toyozumi, Hideaki Shimada

|Jul 03, 2025

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.

Fumiaki Shiratori, Naoto Fujiwara, Yasuaki Nakajima

|Apr 23, 2025

Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients.

Mitsunori Ushigome, Hideaki Shimada, Masaaki Ito

|Aug 17, 2024

Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Sho Sato, Takashi Suzuki, Takashi Chinen

Pageof 9

Frequent Collaborators

Makoto Sumazaki

Takeshi Toyozumi

Fumiaki Shiratori

Rei Okada

Kazuyuki Matsushita

Sohei Kobayashi

Yoko Oshima

Toshiaki Yasuoka

Keiichi Matsubara

Kenzaburo Tani

Frequent Collaborators

Makoto Sumazaki

Takeshi Toyozumi

Fumiaki Shiratori

Rei Okada